Drug factory · FDA FEI 3008264101

Nippon Sanso Matheson, Inc.

1255 SW Brookside Cir, Grimes, IA, United States

United States: 1

No problems found at FDA's last inspection, Apr 20, 2022.

No Action Indicated: inspectors found no objectionable conditions.

2 drug inspections on record since 2013: 2 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
NitrogenMakes it Nippon Sanso Matheson, Inc. 55037-201
OxygenMakes it Nippon Sanso Matheson, Inc. 55037-113

FDA inspection history

EndedResultProgramProblems noted
Apr 20, 2022No problems foundDrug Quality Assurance—
Oct 28, 2013No problems foundDrug Quality Assurance—

Registered with FDA for: manufacture.